3851 - 3875 of 6295 Results
Title
Year
-
OPENTitle: Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00317-8Best OA location URL: https://www.nature.com/articles/s41531-022-00317-8.pdfCitation Count: 4
-
OPENTitle: Clinical trajectories and biomarkers for weight variability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00362-3Best OA location URL: https://www.nature.com/articles/s41531-022-00362-3.pdfCitation Count: 15
- Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment2022OPENTitle: Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00326-7Best OA location URL: https://www.nature.com/articles/s41531-022-00326-7.pdfCitation Count: 20
- Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy2022OPENTitle: Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00335-6Best OA location URL: https://www.nature.com/articles/s41531-022-00335-6.pdfCitation Count: 15
- Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease2022OPENTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 14
-
OPENTitle: Lipid level alteration in human and cellular models of alpha synuclein mutationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00313-yBest OA location URL: https://www.nature.com/articles/s41531-022-00313-y.pdfCitation Count: 14
- Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severity2022OPENTitle: Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00372-1Best OA location URL: https://www.nature.com/articles/s41531-022-00372-1.pdfCitation Count: 13
- Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers2022OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 8
- Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts2022OPENTitle: Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00439-zBest OA location URL: https://www.nature.com/articles/s41531-022-00439-z.pdfCitation Count: 62
-
OPENTitle: The Regulation of ImmunityJournal Name: The Journal of ImmunologyPublisher: Oxford University Press (OUP)Vol: 208Issue #: 11Start Page: 2450End Page: 2455Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2290007Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/208/11/2450/1501657/ji2290007.pdfCitation Count: 0
-
OPENTitle: Power and Sample Size for Longitudinal Models in R -- The longpower Package and Shiny AppJournal Name: The R JournalPublisher: The R FoundationVol: 14Issue #: 1Start Page: 264End Page: 282Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32614/rj-2022-022Best OA location URL: https://journal.r-project.org/articles/RJ-2022-022/RJ-2022-022.pdfCitation Count: 31
-
OPENTitle: Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 PandemicJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 15Issue #: 1Start Page: 77End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20126Best OA location URL: https://doi.org/10.14802/jmd.20126Citation Count: 3
-
OPENTitle: Dancing Feet Dyskinesia in a Patient with GBA-PDJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 15Issue #: 1Start Page: 83End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20169Best OA location URL: https://doi.org/10.14802/jmd.20169Citation Count: 0
-
OPENTitle: Physical activity and exercise for people with Parkinson’sJournal Name: Advances in Clinical Neuroscience & RehabilitationPublisher: Whitehouse PublishingVol: 21Issue #: 2Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.47795/fenh4822Best OA location URL: https://acnr.co.uk/download/22608/Citation Count: 1
- Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity2022OPENTitle: Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 956End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12697Best OA location URL: https://doi.org/10.1002/alz.12697Citation Count: 47
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 36
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study2022OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 12
- The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery2022OPENTitle: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discoveryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1889End Page: 1897Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12514Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12514Citation Count: 18
- Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease2022OPENTitle: Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 2Start Page: 632End Page: 645Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12684Best OA location URL: https://doi.org/10.1002/alz.12684Citation Count: 8
- Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose2022OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://escholarship.org/uc/item/8nk3j1qrCitation Count: 13
- Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE study2022OPENTitle: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE studyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12263Best OA location URL: https://escholarship.org/uc/item/6sd39197Citation Count: 12
-
OPENTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Citation Count: 5
- Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons2022OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 42
-
OPENTitle: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potentialJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12274Citation Count: 25
- Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study2022OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://doi.org/10.1002/trc2.12329Citation Count: 16